Literature DB >> 20392230

Vitamin D action : Lessons learned from genetic mouse models.

David Goltzman1.   

Abstract

Mouse models with targeted deletion of the genes encoding the enzyme 25-hydroxyvitamin D 1alpha-hydroxylase [1alpha(OH)ase], and the vitamin D receptor (VDR), have provided considerable insight into the regulation of mineral and skeletal physiology by 1,25-dihydroxyvitamin D [1,25(OH)(2)D]. Dietary manipulation induced different phenotypic changes and demonstrated that parathyroid gland function is coordinately regulated by calcium and 1,25(OH)(2)D, but that mineralization of bone reflects ambient calcium (and phosphorus) levels rather than direct actions of the 1,25(OH)(2)D/VDR system. In contrast, increased calcium absorption and optimal osteoblastogenesis and bone formation is modulated by the 1,25(OH)(2)D/VDR system. Similar models have also been employed to study extraskeletal vitamin D actions. For example, increased blood pressure, activation of the renin/angiotensin system, myocardial hypertrophy, and cardiac dysfunction were observed in 1alphaOHase(-/-) mice, and could be prevented by 1,25(OH)(2)D(3) administration. These models allow controlled examination of the pathophysiology associated with1,25(OH)(2)D deficiency and intervention to prevent and treat these disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392230     DOI: 10.1111/j.1749-6632.2009.05226.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.

Authors:  Amy L Skversky; Juhi Kumar; Matthew K Abramowitz; Frederick J Kaskel; Michal L Melamed
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 2.  The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.

Authors:  J Keller; T Schinke
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

3.  Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2 , vitamin D3 , 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.

Authors:  Jiri Adamec; Amber Jannasch; Jianjie Huang; Emily Hohman; James C Fleet; Munro Peacock; Mario G Ferruzzi; Berdine Martin; Connie M Weaver
Journal:  J Sep Sci       Date:  2010-11-16       Impact factor: 3.645

4.  A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets.

Authors:  Q Cheng; Y C Li; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2011-03-20       Impact factor: 10.122

5.  [Calcium and vitamin D in osteology].

Authors:  M Amling; F Barvencik
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

6.  [Vitamin D metabolism of the bone].

Authors:  F Barvencik; M Amling
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

Review 7.  Vitamin D safety and requirements.

Authors:  Francisco J A de Paula; Clifford J Rosen
Journal:  Arch Biochem Biophys       Date:  2011-12-09       Impact factor: 4.013

Review 8.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  1,25-Dihydroxyvitamin D insufficiency accelerates age-related bone loss by increasing oxidative stress and cell senescence.

Authors:  Wanxin Qiao; Shuxiang Yu; Haijian Sun; Lulu Chen; Rong Wang; Xuan Wu; David Goltzman; Dengshun Miao
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats.

Authors:  Chu-Lin Chou; Cheng-Yoong Pang; Tony J F Lee; Te-Chao Fang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.